Park JY - Search Results

1

Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer.

Choi SH, Yoo SS, Lee SY, Park JY. Choi SH, et al. Among authors: park jy. Arch Pharm Res. 2022 Apr;45(4):263-279. doi: 10.1007/s12272-022-01382-6. Epub 2022 Apr 21. Arch Pharm Res. 2022. PMID: 35449345 Review.

2

Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer.

Lee EB, Park TI, Park SH, Park JY. Lee EB, et al. Among authors: park jy, park ti, park sh. Ann Thorac Surg. 2003 May;75(5):1597-600. doi: 10.1016/s0003-4975(02)04902-0. Ann Thorac Surg. 2003. PMID: 12735585

3

Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.

Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, Son JW, Kim CH, Lee WK, Kam S, Park RW, Park TI, Kang YM, Kim IS, Jung TH, Park JY. Lee SJ, et al. Among authors: park jy, park sh, park rw, park ti. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):571-5. doi: 10.1158/1055-9965.EPI-04-0472. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767331

4

MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer.

Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH, Lee JT, Jung TH, Park JY. Sohn JW, et al. Among authors: park jy. Jpn J Clin Oncol. 2006 Mar;36(3):137-41. doi: 10.1093/jjco/hyi231. Epub 2006 Feb 14. Jpn J Clin Oncol. 2006. PMID: 16478794

5

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY. Bae NC, et al. Among authors: park jy, park ti. Cancer Genet Cytogenet. 2007 Mar;173(2):107-13. doi: 10.1016/j.cancergencyto.2006.10.007. Cancer Genet Cytogenet. 2007. PMID: 17321325

6

Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population.

Kim DS, Cha SI, Lee JH, Lee YM, Choi JE, Kim MJ, Lim JS, Lee EB, Kim CH, Park TI, Jung TH, Park JY. Kim DS, et al. Among authors: park jy, park ti. Lung Cancer. 2007 Oct;58(1):1-6. doi: 10.1016/j.lungcan.2007.04.008. Epub 2007 May 25. Lung Cancer. 2007. PMID: 17532092

7

Aberrant methylation of ADAMTS1 in non-small cell lung cancer.

Choi JE, Kim DS, Kim EJ, Chae MH, Cha SI, Kim CH, Jheon S, Jung TH, Park JY. Choi JE, et al. Among authors: park jy. Cancer Genet Cytogenet. 2008 Dec;187(2):80-4. doi: 10.1016/j.cancergencyto.2008.08.001. Cancer Genet Cytogenet. 2008. PMID: 19027488

8

Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.

Kim DS, Kim MJ, Lee JY, Lee SM, Choi JE, Lee SY, Park JY. Kim DS, et al. Among authors: park jy. Lung Cancer. 2009 Aug;65(2):247-50. doi: 10.1016/j.lungcan.2009.03.011. Epub 2009 Apr 11. Lung Cancer. 2009. PMID: 19362748

9

Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.

Yoo SS, Choi JE, Lee WK, Choi YY, Kam S, Kim MJ, Jeon HS, Lee EB, Kim DS, Lee MH, Kim IS, Jheon S, Park JY. Yoo SS, et al. Among authors: park jy. J Clin Oncol. 2009 Dec 1;27(34):5823-9. doi: 10.1200/JCO.2009.23.1738. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826114

10

PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.

Jin G, Kim MJ, Jeon HS, Choi JE, Kim DS, Lee EB, Cha SI, Yoon GS, Kim CH, Jung TH, Park JY. Jin G, et al. Among authors: park jy. Lung Cancer. 2010 Sep;69(3):279-83. doi: 10.1016/j.lungcan.2009.11.012. Epub 2009 Dec 16. Lung Cancer. 2010. PMID: 20018398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,970 results

Search Page